Stay updated on CDX-0159 in Chronic Urticaria: Clinical Trial
Sign up to get notified when there's something new on the CDX-0159 in Chronic Urticaria: Clinical Trial page.

Latest updates to the CDX-0159 in Chronic Urticaria: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedExpanded the Locations section to include study sites across the US, Germany, and South Africa and updated the page to version v3.3.3. The HHS Vulnerability Disclosure link was removed.SummaryDifference2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0 on the page; no visible changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedA site-wide government funding/operating status notification was removed from the page, and the study details remain unchanged.SummaryDifference0.3%

- Check62 days agoChange DetectedDifference0.3%

- Check91 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference3%

- Check98 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no substantive content changes.SummaryDifference0.1%

Stay in the know with updates to CDX-0159 in Chronic Urticaria: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CDX-0159 in Chronic Urticaria: Clinical Trial page.